Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 10 | $3,893,256 |
Sells | 3 | $112,307 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
31 Jan 2024 16:26 | TRML | Tourmaline Bio Inc | MCDADE MARK | Director | 29 Jan 2024 | Purchase | 100,000 | 32.5 | 3,250,000 | I |
20 Nov 2023 18:15 | TRML | Tourmaline Bio Inc | KULKARNI SANDEEP CHIDAMBAR | CEO | 17 Nov 2023 | Purchase | 4,000 | 16.99 | 67,960 | D |
20 Nov 2023 18:14 | TRML | Tourmaline Bio Inc | THIARA PARVINDER | Director | 17 Nov 2023 | Purchase | 1,000 | 17.31 | 17,310 | D |
27 Oct 2023 17:43 | TRML | Tourmaline Bio Inc | CASTELEIN CALEY | Director | 27 Oct 2023 | Purchase | 15,800 | 14.55 | 229,890 | D |
27 Oct 2023 17:43 | TRML | Tourmaline Bio Inc | CASTELEIN CALEY | Director | 25 Oct 2023 | Purchase | 4,200 | 12.07 | 50,694 | D |
26 Oct 2023 17:34 | TRML | Tourmaline Bio Inc | KULKARNI SANDEEP CHIDAMBAR | CEO | 26 Oct 2023 | Purchase | 5,000 | 12.25 | 61,250 | D |
26 Oct 2023 17:34 | TRML | Tourmaline Bio Inc | KULKARNI SANDEEP CHIDAMBAR | CEO | 24 Oct 2023 | Purchase | 4,650 | 10.68 | 49,662 | D |
26 Oct 2023 17:00 | TRML | Tourmaline Bio Inc | KANTOFF AARON | Director | 24 Oct 2023 | Purchase | 7,500 | 11.86 | 88,950 | D |
26 Oct 2023 16:46 | TRML | Tourmaline Bio Inc | THIARA PARVINDER | Director | 25 Oct 2023 | Purchase | 2,000 | 12.12 | 24,240 | D |
26 Oct 2023 16:46 | TRML | Tourmaline Bio Inc | THIARA PARVINDER | Director | 24 Oct 2023 | Purchase | 5,000 | 10.66 | 53,300 | D |
14 Jun 2023 18:58 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 14 Jun 2023 | Sale | 12,942 | 2.4914 | 32,244 | D |
14 Jun 2023 18:58 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 13 Jun 2023 | Sale | 14,208 | 2.5576 | 36,338 | D |
14 Jun 2023 18:58 | TRML | Talaris Therapeutics Inc | ILDSTAD SUZANNE | Director | 12 Jun 2023 | Sale | 16,870 | 2.5919 | 43,725 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)